The vesicular stomatitis virus matrix protein inhibits transcription from the human beta interferon promoter - PubMed (original) (raw)
The vesicular stomatitis virus matrix protein inhibits transcription from the human beta interferon promoter
M C Ferran et al. J Virol. 1997 Jan.
Abstract
In cells infected by wild-type (wt) vesicular stomatitis virus (VSV) Indiana, host transcription is severely inhibited. DNA cotransfection studies have implicated the VSV matrix (M) protein in this process (B. L. Black and D. S. Lyles, J. Virol. 66:4058-4064, 1992). The M protein inhibited transcription not only from viral promoters in plasmids but also from the chromosomally integrated human immunodeficiency virus type 1 (HIV-1) provirus promoter (S.-Y. Paik, A. C. Banerjea, G. G. Harmison, C.-J. Chen, and M. Schubert, J. Virol. 69:3529-3537, 1995). In this study, we investigated the effect of wt VSV M protein on expression of a reporter gene under control of a cellular promoter (beta-interferon [IFN-beta] promoter), using double transient transfections in BHK and COS-1 cells. The cellular IFN-beta promoter was as susceptible to the inhibitory effect of the M protein as the viral promoters used previously. Viral proteins N, P, and G had no significant effect on reporter gene expression. The M protein gene from VSV mutant T1026R1, which is defective in host transcription inhibition, was cloned and sequenced, and its effect on reporter gene expression was tested. The mutant M protein had a methionine-to-arginine change at position 51 in the protein sequence and did not inhibit transcription from either the IFN-beta promoter or viral promoters. This VSV mutant is a good inducer of IFN, as opposed to the wt virus, which suppresses IFN induction. These results show that the M protein inhibits transcription from cellular as well as viral promoters and that the M protein does not regulate the IFN promoter any differently from viral promoters. While the M protein may play a role in IFN gene regulation, other viral or cellular factors that provide specificity to the induction process must also be involved.
Similar articles
- Ability of the matrix protein of vesicular stomatitis virus to suppress beta interferon gene expression is genetically correlated with the inhibition of host RNA and protein synthesis.
Ahmed M, McKenzie MO, Puckett S, Hojnacki M, Poliquin L, Lyles DS. Ahmed M, et al. J Virol. 2003 Apr;77(8):4646-57. doi: 10.1128/jvi.77.8.4646-4657.2003. J Virol. 2003. PMID: 12663771 Free PMC article. - Inducible and conditional inhibition of human immunodeficiency virus proviral expression by vesicular stomatitis virus matrix protein.
Paik SY, Banerjea AC, Harmison GG, Chen CJ, Schubert M. Paik SY, et al. J Virol. 1995 Jun;69(6):3529-37. doi: 10.1128/JVI.69.6.3529-3537.1995. J Virol. 1995. PMID: 7745700 Free PMC article. - Potency of wild-type and temperature-sensitive vesicular stomatitis virus matrix protein in the inhibition of host-directed gene expression.
Lyles DS, McKenzie MO, Ahmed M, Woolwine SC. Lyles DS, et al. Virology. 1996 Nov 1;225(1):172-80. doi: 10.1006/viro.1996.0585. Virology. 1996. PMID: 8918544 - Reviewing Chandipura: a vesiculovirus in human epidemics.
Basak S, Mondal A, Polley S, Mukhopadhyay S, Chattopadhyay D. Basak S, et al. Biosci Rep. 2007 Oct;27(4-5):275-98. doi: 10.1007/s10540-007-9054-z. Biosci Rep. 2007. PMID: 17610154 Free PMC article. Review. - Divergent promoters, a common form of gene organization.
Beck CF, Warren RA. Beck CF, et al. Microbiol Rev. 1988 Sep;52(3):318-26. doi: 10.1128/mr.52.3.318-326.1988. Microbiol Rev. 1988. PMID: 3054465 Free PMC article. Review. No abstract available.
Cited by
- Exploring the Molecular Basis of Vesicular Stomatitis Virus Pathogenesis in Swine: Insights from Expression Profiling of Primary Macrophages Infected with M51R Mutant Virus.
Velazquez-Salinas L, Medina GN, Valdez F, Zarate S, Collinson S, Zhu JJ, Rodriguez LL. Velazquez-Salinas L, et al. Pathogens. 2023 Jun 30;12(7):896. doi: 10.3390/pathogens12070896. Pathogens. 2023. PMID: 37513744 Free PMC article. - Computational prediction of intracellular targets of wild-type or mutant vesicular stomatitis matrix protein.
Morris MC, Russell TM, Lyman CA, Wong WK, Broderick G, Ferran MC. Morris MC, et al. PLoS One. 2022 Feb 2;17(2):e0263065. doi: 10.1371/journal.pone.0263065. eCollection 2022. PLoS One. 2022. PMID: 35108303 Free PMC article. - TLR3 controls constitutive IFN-β antiviral immunity in human fibroblasts and cortical neurons.
Gao D, Ciancanelli MJ, Zhang P, Harschnitz O, Bondet V, Hasek M, Chen J, Mu X, Itan Y, Cobat A, Sancho-Shimizu V, Bigio B, Lorenzo L, Ciceri G, McAlpine J, Anguiano E, Jouanguy E, Chaussabel D, Meyts I, Diamond MS, Abel L, Hur S, Smith GA, Notarangelo L, Duffy D, Studer L, Casanova JL, Zhang SY. Gao D, et al. J Clin Invest. 2021 Jan 4;131(1):e134529. doi: 10.1172/JCI134529. J Clin Invest. 2021. PMID: 33393505 Free PMC article. - The VSV matrix protein inhibits NF-κB and the interferon response independently in mouse L929 cells.
Marquis KA, Becker RL, Weiss AN, Morris MC, Ferran MC. Marquis KA, et al. Virology. 2020 Sep;548:117-123. doi: 10.1016/j.virol.2020.06.013. Epub 2020 Jun 29. Virology. 2020. PMID: 32838932 Free PMC article. - MAP3K7 and CHD1 Are Novel Mediators of Resistance to Oncolytic Vesicular Stomatitis Virus in Prostate Cancer Cells.
Bayne RS, Puckett S, Rodrigues LU, Cramer SD, Lee J, Furdui CM, Chou JW, Miller LD, Ornelles DA, Lyles DS. Bayne RS, et al. Mol Ther Oncolytics. 2020 May 20;17:496-507. doi: 10.1016/j.omto.2020.05.004. eCollection 2020 Jun 26. Mol Ther Oncolytics. 2020. PMID: 32529027 Free PMC article.
References
- Virology. 1966 Jan;28(1):1-10 - PubMed
- J Interferon Res. 1994 Apr;14(2):71-9 - PubMed
- J Virol. 1970 Oct;6(4):476-84 - PubMed
- Cell. 1977 Jun;11(2):273-81 - PubMed
- Cell. 1978 Dec;15(4):1455-62 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources